Ballentine Partners, LLC Arcutis Biotherapeutics, Inc. Transaction History

Ballentine Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 19, 2023	BUY	$5.31 - $10.98 $1,492 - $3,085	281 Added 2.78%	10,386 $55,000
Q2 2023 Jul 26, 2023	SELL	$7.51 - $15.0 $660 - $1,320	-88 Reduced 0.86%	10,105 $96,000
Q1 2023 Apr 27, 2023	BUY	$10.23 - $17.14 $104,274 - $174,708	10,193 New	10,193 $112,000
Q3 2021 Oct 27, 2021	SELL	$19.28 - $27.1 $142,228 - $199,916	-7,377 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$24.42 - $34.75 $180,146 - $256,350	7,377 New	7,377 $201,000

252

127M

404K

133K

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $1.5B
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

Get notified when there are updates to the investment portfolio of Ballentine Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Ballentine Partners, LLC with notifications on news.